Interestingly, these two samples showed strikingly high expression in CDKN2A (669.8 and 349.74 respectively calculated in TPM, Table 1) which is not compatible with characteristics of EBV associated STAD. The gene discussed is CDKN2A; the disease is gastric adenocarcinoma.